Nurix Therapeutics, Inc. (NRIX) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$5,435
Total Return
-45.65%
CAGR
-11.48%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +0.98% |
| Median | -2.27% |
| Best | +86.21% |
| Worst | -50.12% |
| % of Windows Positive | 44.4% |
1-Year (252 Trading Days)
| Average | +8.40% |
| Median | -30.03% |
| Best | +518.12% |
| Worst | -69.55% |
| % of Windows Positive | 32.3% |
3-Year (756 Trading Days)
| Average | -5.85% |
| Median | -16.35% |
| Best | +85.65% |
| Worst | -65.51% |
| % of Windows Positive | 31.7% |
Risk Metrics
| Maximum Drawdown | -88.42% |
| Average Drawdown | -55.44% |
| Drawdown Duration | 1151 Trading Days (Unrecovered) |
| Sortino Ratio | 0.30 |
| Calmar Ratio | -0.13 |
| CVaR (5%) | -9.53% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -14.07% (-41.30% ann.) | $1407.49 | $0.00 | $0.00 | $0.00 |
| 2025 | +0.69% | +$69.01 | $0.00 | $0.00 | $0.00 |
| 2024 | +82.56% | +$8255.81 | $0.00 | $0.00 | $0.00 |
| 2023 | -6.01% | $601.10 | $0.00 | $0.00 | $0.00 |
| 2022 | -62.07% | $6207.25 | $0.00 | $0.00 | $0.00 |
| 2021 | -11.95% | $1195.25 | $0.00 | $0.00 | $0.00 |
| 2020 partial | +72.96% (+249.30% ann.) | +$7296.16 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Policy bazooka / monetary euphoria partial | July 24, 2020 – November 6, 2020 | +21.99% | +99.65% | +$2198.84 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +26.39% | +24.88% | +$2638.95 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -58.36% | -60.56% | $5836.22 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +80.85% | +37.66% | +$8084.50 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | -34.11% | -23.35% | $3411.48 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.